The most common grade @ or worse events were hand-foot syndrome ( @ -LSB- @ % -RSB- in the bevacizumab and capecitabine group vs none in the bevacizumab alone group ) , hypertension ( eight -LSB- @ % -RSB- vs three -LSB- @ % -RSB- ) , and proteinuria ( three -LSB- @ % -RSB- vs four -LSB- @ % -RSB- ) .